- Corporate Governance
- Board of Directors
- News Releases
- SEC Filings
- Financial Reporting
- Events and Webcasts
- Investor Alerts
Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.
We currently have 28 topical Abbreviated New Drug Applications (ANDAs) on file at the FDA, representing a total addressable market of $1.5 billion (IMS, September 2015). We also have one injectable Prior Approval Supplement (PAS) on file with the FDA.
We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.
‘’As we grow, we will keep our focus on execution, ownership and delivering on what we promise.’’